Correlation Between Recursion Pharmaceuticals and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Atea Pharmaceuticals, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Atea Pharmaceuticals.
Diversification Opportunities for Recursion Pharmaceuticals and Atea Pharmaceuticals
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Recursion and Atea is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Atea Pharmaceuticals
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 2.01 times more return on investment than Atea Pharmaceuticals. However, Recursion Pharmaceuticals is 2.01 times more volatile than Atea Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest 721.00 in Recursion Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 3.00 from holding Recursion Pharmaceuticals or generate 0.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Recursion Pharmaceuticals vs. Atea Pharmaceuticals
Performance |
Timeline |
Recursion Pharmaceuticals |
Atea Pharmaceuticals |
Recursion Pharmaceuticals and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Recursion Pharmaceuticals and Atea Pharmaceuticals
The main advantage of trading using opposite Recursion Pharmaceuticals and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |